Today's Edition
ABU DHABI (ALETIHAD)
PureHealth Holding, the largest healthcare group in the Middle East, posted a net profit of Dh1.03 billion for the first half of 2025, up 2% year-on-year, as both its Healthcare (Care) and Insurance (Cover) verticals delivered strong performance. Revenue for the period rose 9% to Dh13.6 billion, while EBITDA reached Dh2.3 billion, up 8%.
The Care vertical remained the key contributor to the group’s top line, accounting for 72% of total revenue, or Dh9.8 billion, supported by robust demand across hospitals, diagnostics, and technology. Hospital visits increased notably, with outpatient volumes rising 13% to 4.4 million and inpatient volumes up 7% to 108,000. Growth in the UAE was bolstered by enhanced services and expanded specialist capacity across the SEHA and SSMC networks. In the UK, Circle Health’s acquisition of Fairfield Independent Hospital added inpatient capacity and extended its presence in high-demand regions.
Within the diagnostics segment, PureLab saw a 19% rise in testing volumes to 16.9 million, aided by the integration of SSMC’s laboratory. Technology Services also posted remarkable growth, with revenue soaring 170% to Dh367 million, driven by the expansion of PureCS and increased user adoption of the Pura app, which surpassed 620,000 users.
The Cover vertical contributed Dh3.8 billion in revenue, a 14% increase, while gross written premiums climbed to Dh4.9 billion. The Group’s membership base rose by 6%, reflecting solid customer retention and growth into underpenetrated markets.
“Our strong performance in the first half of 2025 reflects the profound ambition driving our transformation,” said Kamal Al Maazmi, Chairman of PureHealth. “By aligning innovation with national priorities and international partnerships, we are reshaping how health is delivered, experienced, and sustained.”
Group CEO Shaista Asif said, “We delivered solid growth across both our Care and Cover verticals. As we expand globally, our focus remains on transformation, synergies, and delivering better health outcomes.”
PureHealth ended the period with a healthy balance sheet, repaying Dh1.85 billion in bank debt and maintaining a Net Debt to EBITDA ratio of 1.4x. The Group continues to pursue international expansion, including the acquisition of Hellenic Healthcare Group in Greece and Cyprus, pending EU regulatory approval.
